Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

By LabMedica International staff writers
Posted on 22 Jul 2025

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. More...

Accurate prediction of resistance is crucial for effective treatment, yet traditional methods such as bacterial antimicrobial susceptibility tests (ASTs) are inefficient. Predictive models based on whole-genome sequencing (WGS) data also face challenges, particularly overfitting due to the high dimensionality of genomic data. Additionally, these models struggle with imbalances in the number of resistant and sensitive samples, further limiting their reliability. Now, researchers have developed an innovative prediction platform that integrates advanced artificial intelligence (AI) and quantum computing technologies to improve accuracy and efficiency in antimicrobial-resistance prediction.

The new solution, developed by scientists at Sichuan University (Chengdu, China), is called the Salmonella Antimicrobial-Resistance Predictive platform based on Large Language Models (SARPLLM). It employs a two-step feature-selection process that begins with a chi-square test and conditional mutual information maximization to identify key resistance genes through pan-genomic analysis. The SARPLLM algorithm itself is based on the Qwen2 large language model and incorporates low-rank adaptation (LoRA) to convert Salmonella samples into sentence-like structures for AI processing.

To resolve data imbalance, the researchers created the QSMOTEN algorithm—an advancement of the SMOTEN method that uses quantum computing to encode genomic features into quantum states and calculate sample distances more efficiently, reducing computational complexity from linear to logarithmic scale. In addition, the team launched a user-friendly online platform built with Django as the back-end and Echarts for knowledge graph visualization. It includes modules for resistance prediction, pan-genomic results, gene-antimicrobial interaction mapping, and data downloads.

Experimental validation showed that SARPLLM achieved higher F1-scores than existing models for multiple antimicrobials, while QSMOTEN demonstrated strong performance on both virtual and physical quantum machines in computing genomic similarities. The study, published in Engineering, confirms that combining AI with quantum computing can significantly accelerate and enhance resistance prediction. The platform’s practical utility is strengthened by its ability to provide online data processing, visualization, and downloadable results.

However, researchers noted that current large language models still struggle to fully grasp the complex biological and genetic foundations of antimicrobial resistance, and that the accuracy of predictions is influenced by the quality of training data. The team plans to integrate multi-source data and domain-specific knowledge in future iterations and to advance more stable quantum hardware to improve performance further.


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.